Hvsen Biotechnology Co., Ltd. (300871.SZ) SHZ
20.60
-0.14(-0.68%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Hvsen Biotechnology Co., Ltd.
Sector
Healthcare
Industry
Biotechnology
Employees
1068
First IPO Date
August 24, 2020
Key Executives
| Name | Title | Pay | Year Born |
| Qingfeng Wang | Board Secretary | 0 | 1989 |
| Wenge Ding | Product & Technical Service Director and Supervisor | 0 | 1969 |
| Hongxia Li | Director of Warehousing & Logistics Data and Supervisor | 0 | 1976 |
| Kaijie Yang | Deputy GM & Chief Financial Officer | 0 | 1970 |
| Zexiang Liu | Director & Assistant to the GM | 0 | 1976 |
| Qiongbi Luo | Accounting Supervisor | 0 | N/A |
| Hujie Yu | Deputy General Manager | 0 | 1985 |
| Jinbin Huang | Deputy General Manager | 0 | 1982 |
| Shuo Li | Deputy General Manager | 0 | 1980 |
| Jie Han | Rotating General Manager | 0 | 1985 |
Description
Hvsen Biotechnology Co., Ltd. engages in the research and development, and manufacture of macrolides APIs and preparations in China and internationally. Its products include tylvalosin raw materials, various tylvalosin preparations, florfenicol preparations, and other macrolides products. The company produces various veterinary drug products of raw materials and preparations, as well as traditional Chinese medicines extractives. Hvsen Biotechnology Co., Ltd. is based in Wuhan, China.
